Related Experiment Video
Updated: Jul 27, 2025

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
Published on: March 15, 2016
VEGF-A related SNPs: a cardiovascular context.
J C Meza-Alvarado1, R A Page1, B Mallard1
1School of Health Sciences, Massey University, Wellington, New Zealand.
Vascular Endothelial Growth Factor-A (VEGF-A) shows promise as a biomarker for cardiovascular disease (CVD) risk. Genetic variations (SNPs) influencing VEGF-A levels may predict CVD development and associated risk factors.
Area of Science:
- Cardiovascular Science
- Genetics
- Biomarker Discovery
Background:
- Cardiovascular diseases (CVDs) are a leading global cause of mortality.
- Current CVD risk algorithms lack predictive biomarkers for early detection.
- Vascular Endothelial Growth Factor-A (VEGF-A) is crucial for blood vessel formation and a potential CVD biomarker.
Purpose of the Study:
- To review the VEGF family, focusing on VEGF-A.
- To summarize single nucleotide polymorphisms (SNPs) affecting VEGF-A plasma levels.
- To explore the association of VEGF-A SNPs with CVD and CVD risk factors.
Main Methods:
- Literature review of the VEGF family and VEGF-A.
- Analysis of studies reporting SNPs influencing VEGF-A levels.
- Examination of research linking VEGF-A variants to CVD and risk factors.
Main Results:
- VEGF-A plays a complex role in the cardiovascular system.
- Specific SNPs have been associated with altered circulating VEGF-A levels.
- These VEGF-A variants show links to CVD development and risk factor profiles.
Conclusions:
- VEGF-A is a significant molecule in cardiovascular health.
- Genetic variations in VEGF-A influence its circulating levels and CVD risk.
- VEGF-A SNPs represent potential biomarkers for cardiovascular disease risk assessment.
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
Single Nucleotide Polymorphisms-SNPs
Comparing Copy Number Variations and SNPs
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...

